Conducting clinical trials in the Czech Republic with Cromos Pharma

Cromos Pharma has been managing clinical trials in the Czech Republic since the 2010s and established a permanent office in its capital Prague in 2015. Czechia is recognized as an attractive location for international clinical trials with a strong track record for producing high-quality data and lengthy experience in Good Clinical Practices provided by the ICH-GCP.
Czechia is recognized as an attractive location for international clinical trials with a strong track record for producing high-quality data and lengthy experience in Good Clinical Practices provided by the ICH-GCP. Cromos Pharma has been managing clinical trials in the Czech Republic since the 2010s and established a permanent office in its capital Prague in 2015.

Read Cromos Pharma’s Czech Republic Country Profile here>>

The advantages of conducting clinical trials in Czechia

  1. With a population of just over 10.6 million, the Czech Republic offers excellent recruitment potential due to its large population of modern treatment-naïve patients in a wide range of therapeutic areas.
  2. It is recognized as an attractive location for international clinical trials with a strong track record for producing high-quality data and lengthy experience in Good Clinical Practices provided by the ICH-GCP
  3. The Czech Republic is the second largest pharma market in Central and Eastern Europe – valued at €2.95 billion in 2019.This pharma market has demonstrated strong growth in recent years in the innovative drug market – €1.6 billion in 2021.
  4. Its regulatory authority the State Institute for Drug Control (SUKL) has a reputation for being open, efficient, and supportive in its approach to supporting clinical research. This allows for quick approval periods and expedited start-up timelines (on average 60 days).
  5. The country has a Universal Healthcare System conducive to patient enrollment. In addition, it boasts a large network of public hospitals and clinics as well as specialized centres for patients with specific diagnoses.
  6. The country has a large pool of highly educated and skilled medical professionals with 10 medical faculties in 6 universities including the internationally renowned Institute of Clinical and Experimental Medicine (IKEM) in Prague and Masaryk Memorial Cancer Institute (MMCI) in Brno.
  7. An EU member since 2004, its clinical trial regulatory and legislative framework is harmonized with EU directives in relation to clinical research.

EUCTR

The way clinical trials are conducted in the EU will undergo a major overhaul when the Clinical Trial Regulation comes into effect. The Regulation harmonizes the assessment and supervision processes for clinical trials throughout the EU via a publicly available Clinical Trials Information System (CTIS; formerly the EU Clinical Trial Portal and Database). The European Medicines Agency (EMA) will set up and maintain the new information system, in collaboration with the member states and the European Commission. It is currently estimated that the Regulation will enter into effect by January 2022.

About Cromos Pharma

Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 16 years’ experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

Contact us today at bd@cromospharma.com to set up an introductory meeting to explore how Cromos Pharma can support your next clinical project.

*page updated 14 October 2021 with new pdf link

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.